| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | China | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Republic of Korea | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 3 | |
| #6 | United States | 2 | |
| #7 | Canada | 1 | |
| #8 | Israel | 1 | |
| #9 | Japan | 1 | |
| #10 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kumon Hiromi | 20 |
| #2 | Watanabe Masami | 8 |
| #3 | Lowenthal Richard | 7 |
| #4 | Nasu Yasutomo | 6 |
| #5 | Kashiwakura Yuji | 6 |
| #6 | Futami Junichiro | 3 |
| #7 | Kinoshita Rie | 3 |
| #8 | Kawasaki Kensuke | 2 |
| #9 | Sakaguchi Masakiyo | 2 |
| #10 | Richard Lowenthal | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021020554A1 | Method for treating liver cancer with combined use of reic/dkk-3 gene and anti-tumor agent | |
| WO2020091066A1 | A combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor | |
| EP3485895A1 | TGF INHIBITOR CONTAINING REIC/Dkk-3 PROTEIN AS ACTIVE INGREDIENT | |
| EP3400024A1 | A combination therapy using reic/dkk-3 gene and a checkpoint inhibitor |